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Natural-killer group 2 member D (NKG2D) is a well-characterized activating receptor 
expressed by natural killer (NK) cells, NKT cells, activated CD8+ T cells, subsets of γδ+ 
T  cells, and innate-like T  cells. NKG2D recognizes multiple ligands (NKG2D-ligands) 
to mount an innate immune response against stressed, transformed, or infected cells. 
NKG2D-ligand surface expression is tightly restricted on healthy cells through transcrip-
tional and post-transcriptional mechanisms, while transformed or infected cells express 
the ligands as a danger signal. Recent studies have revealed that unfolded protein 
response pathways during endoplasmic reticulum (ER) stress result in upregulation of 
ULBP-related protein via the protein kinase RNA-like ER kinase-activating factor 4-C/
EBP homologous protein (PERK-ATF4-CHOP) pathway, which can be linked to the 
pathogenesis of autoimmune diseases. Transformed cells, however, possess mecha-
nisms to escape NKG2D-mediated immune surveillance, such as upregulation of car-
cinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1), a negative 
regulator of NKG2D-ligands. In this review, we discuss mechanisms of NKG2D-ligand 
regulation, with a focus on newly discovered mechanisms that promote NKG2D-ligand 
expression on epithelial cells, including ER stress, and mechanisms that suppress 
NKG2D-ligand-mediated killing of cancer cells, namely by co-expression of CEACAM1.
Keywords: natural-killer group 2 member D, natural-killer group 2 member D-ligand, murine UL16-binding protein 
like transcript 1, UL16 binding protein 1, endoplasmic reticulum stress, CeA-related cell adhesion molecule 1
inTRODUCTiOn
Natural killer (NK) cells were originally identified as lymphocytes with cytotoxic reactivity against 
several types of cancer cells (1, 2), and are considered to be part of the innate immune cell compart-
ment/family/pool because of lack of rearranged antigen-specific receptors by somatic recombina-
tion. Both activating and inhibitory receptors can regulate NK  cells activity and recognize target 
cells (3). Inhibitory receptors, including killer cell immunoglo bulin (Ig)-like receptors (KIRs) and 
TAbLe 1 | Natural-killer group 2 member D (NKG2D)-ligands regulation by cellular stress.
Type of cellular stress Regulation mechanisms Mouse nKG2D-ligands Human-nKG2D ligands Reference
Oxidative stress MAPK pathway MICA/B, ULBP1-4 (14, 15)
Heat shock Transcriptional (HSF1) 
MULT1
MICA/B (15–20)
Ubiquitin-dependent degradation (E3 ubiquitin ligase)
Endoplasmic reticulum stress Transcriptional (ATF4, CHOP) MULT1 ULBPs (25, 26)
ATF4, activating factor 4; CHOP, CCAAT/enhancer-binding protein (C/EBP) homologous protein; HSF1, heat shock factor 1; MAPK, mitogen-activated protein kinases; MICA/B, 
MHC class I chain-related proteins A/B; MULT1, murine UL16-binding protein like transcript 1; ULBP1, UL16 binding protein 1.
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leukocyte Ig-like receptors in humans, Ly49s in mouse, and 
CD94-Natural-killer group 2 member A receptors in human 
and mouse, recognize major histo compatibility complex (MHC) 
class I. If NK  cells encounter cells that express MHC class I, an 
immune response against these cells is prevented by the inhibitory 
signals through receptor–ligand interactions. In contrast, cells in 
which MHC class I is downre gulated, for example, in virus-infected 
cells or cancer cells, NK cells are activated by the lack of inhibitory 
signals, which makes the “diseased” cells prone to NK cell-mediated 
killing (the missing-self hypothesis) (4). The inhibitory function is 
mediated through immunoreceptor tyrosine-based inhibitory motif 
(ITIM) in the cytoplasmic domain of these inhibitory receptors (5).
Besides inhibitory receptors, numerous activating NK 
receptors, such as CD94-Natural-killer group 2 member 
C, natural-killer group 2 member D (NKG2D), NKp44, 
NKp46, KIRs in humans, Ly49 receptors, in mice have been 
identified (5). The combination of the activation receptors can 
synergistically mediate natural cytotoxicity (6). NKG2D, a 
type II transmembrane-anchored C-type lectin-like acti vating 
receptor, is a well-characterized activation receptor expressed 
by NK  cells, NKT  cells, activated CD8+ T  cells, subsets of 
γδ+ T  cells, and innate-like T  cells, which are TCR+ NK1.1+ 
CD49ahigh CD103+ tissue-resident T  lymphocytes with innate 
cytolytic activities, transcriptionally related to ILC1 (7–11). 
NKG2D can recognize multiple ligands (NKG2D-ligands), which 
are homologous to MHC class I molecules; MHC class I chain-
related proteins A (MICA), MICB, UL16 binding protein 1 
(ULBP1)–ULBP6 in human; retinoic acid early inducible 1 (RAE-1) 
(isoforms α–ε), H60 (isoforms a–c), and murine UL16-binding 
protein like transcript 1 (MULT1) in mouse (12). Interaction 
of these ligands with NKG2D results in NK  cell cytotoxicity 
via signal transducing adapter molecule DAP10 in human and 
both DAP10 and DAP12 in mouse (10). Surface expression of 
NKG2D-ligands on healthy cells is tightly restricted by regulation 
at transcriptional and posttranscriptional levels, to ensure that 
healthy cells are not recognized by the innate immune system. 
The mechanisms involved in NKG2D-ligand expression regula-
tion have been studied extensively [reviewed in Ref. (12, 13)].
Emerging evidence shows that intracellular stress can also 
induce the NKG2D-ligand expression. In this review, we sum-
marize the mechanisms of NKG2D-ligand regulation. We focus 
specifically on recent advances in our understanding of how endo-
plasmic reticulum (ER) stress leads to NKG2D-ligand surface 
expression, and eventually group 1 innate lymphoid cells (ILCs)-
mediated inflammation, particularly inflammatory bowel dis-
eases, which are associated with several ER stress-related genes. 
In addition, we discuss the mechanisms by which NKG2D-L 
are suppressed on the other hand and specifically through car-
cinoembryonic antigen (CEA)-related cell adhesion molecule 1 
(CEACAM1).
ReGULATiOn OF nKG2D-LiGAnDS
Regulation of nKG2D-Ligands by Cellular 
Stress and eR Stress
As NKG2D-ligand expression signals the immune system to rec-
ognize infected or transformed cells, a variety of stress pathways 
have been demonstrated to regulate NKG2D-ligand expression 
via different mechanisms (Table  1). Oxidative stress leads to 
accumulation of H2O2, which induces NKG2D-ligand including 
MICA/B and ULBP1–4 via activation of the mitogen-activated 
protein kinases pathway (14, 15). In contrast, heat shock can 
transcriptionally regulate MICA/B, as the promoter regions of 
the MIC genes have heat shock elements that can be recognized 
by heat shock factor 1 (HSF1) (15–17). Knockdown of HSF1 has 
been shown to suppress MICB, but not MICA, membrane expres-
sion leading to a reduction in NK  cell-mediated cytotoxicity 
(18). In mice, heat shock induces MULT1 protein expression in 
fibroblasts and transformed cells by altering protein stability (19). 
One of the mechanisms associated with regulation of MULT1 
surface expression by heat shock could be the membrane-
associated RING-CH (MARCH) family of E3 ubiquitin ligase. 
While MULT1 is post-transcriptionally regulated by ubiquitin-
dependent degradation by the MARCH family in unstressed cells, 
MULT1 ubiquitination and degradation are reduced in response 
to heat shock stress (19, 20).
Until recently, little was known about how cellular stress that 
leads to disturbances in proteostasis, and eventually ER stress, 
interact with regulation of NKG2D-ligand expression. ER stress 
is caused by the accumulation of unfolded and misfolded proteins 
in the ER arising from either primary (genetic) or secondary 
(environmental) factors (21). Highly secretory cells are highly 
susceptible to ER stress. These include Ig-producing plasma cells, 
insulin-secreting β-cells in the pancreas and intestinal epithelial 
cells, in particular Paneth cells and goblet cells (22). ER stress 
leads to the accumulation of unfolded or misfolded proteins 
within the ER lumen, which triggers three ER stress sensors to 
induce the so-called unfolded protein response (UPR). These 
include inositol-requiring transmembrane kinase-endonuclease 
1 (IRE1), protein kinase RNA-like ER kinase (PERK), and acti-
vated transcription factor 6 (22). The main goal of UPR activation 
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is to restore proteostasis and enhance the secretory capacity of 
the ER. In the IRE1 arm of the UPR, phosphorylated IRE1 pos-
sesses endoribonuclease activity that excises a 26-nucleotide 
sequence of X-box binding protein 1 (Xbp1) mRNA resulting in 
a frame shift and generation of a transcriptionally active isoform 
that functions as a transactivator of UPR target genes.
In the PERK arm, translation is suppressed by phosphory-
lation of elongation initiation factor 2α (eIF2α) to allow the 
cell to temporarily cope with excessive ER stress. Paradoxically, 
translation of some proteins, such as activating factor 4 (ATF4) 
is favored. Initially, ATF4 can induce several protective cellular 
pathways, among others autophagy (see below). However, if ER 
stress is excessive or prolonged, ATF4 induces apoptosis-related 
transcription factors, such as CCAAT/enhancer-binding protein 
(C/EBP) homologous protein (CHOP) (23).
Besides cell death, ER stress elicits inflammatory responses, 
and hence it was hypothesized that UPR-related proteins can 
induce surface expression of NKG2D-ligands. Surprisingly, 
Xbp1 knockdown in the mouse immortalized small intestinal 
epithelial cell line MODE-K (24) (shXbp1 MODE-K by a short 
hairpin Xbp1 lentiviral vector), which causes ER stress (25), 
was shown to induce very strong induction of NKG2D-ligand 
MULT1 (both on mRNA level and surface protein expression), 
whereas inflammatory signals induced after stimulation with a 
variety of TLR ligands did not (25). Even more interesting was 
the fact that it appeared to be specific for MULT1, as both RAE-1 
and H60 were not strongly induced. In contrast, expression of 
MHC class I, which is recognized by NK cell inhibitory recep-
tors, was not affected by Xbp1 knockdown in vitro and knockout 
in vivo. The effect was not specific for Xbp1 deletion, as ER stress 
induction by administration of thapsigargin similarly induced 
strong upregulation of MULT1 surface expression. In addition, 
similar induction of ULBPs (the human ortholog of MULT1) was 
observed in a variety of human cell lines, including intestinal, 
gastric, esophageal, and hepatic cancer cell lines.
Intriguingly, ER stress protein ATF4 was found to be impor-
tant in NKG2D-ligand upregulation using a completely different 
approach in a human cancer cell line HAP1 (26). This cancer cell 
line constitutively expresses ULBP1 and after treatment with a 
retroviral promoter trap vector, which randomly knocks out 
genes, the cell lines that had significant downregulation of ULBP1 
surface expression were screened for gene enrichment. This screen 
revealed that ATF4 is important for the induction of ULBP1, 
which was confirmed by demonstrating that knockdown of ATF4 
strongly decreased ULBP1 transcription. In addition, ATF4 was 
shown to have direct ULBP1 promotor binding sites and directly 
transactivates the ULBP1 promoter (26). In contrast to this study 
in human cancer cell lines, we have identified CHOP as a tran-
scription factor that binds the promoter of the mouse ortholog 
of ULBP1, MULT1, using chromatin immunoprecipitation and 
luciferase assays. CHOP is downstream of PERK-ATF4, but can 
also be induced by other ER stress-associated pathway elements 
(27). Interestingly, MODE-K cells with silenced CHOP using 
shRNA, or primary intestinal epithelial cells from Chop−/− mice 
examined ex vivo show downregulation of ER stress-dependent 
induction of MULT1 on the surface of intestinal epithelial cells 
(Figure 1).
Together, these two recent studies indicate that the PERK–
ATF4–CHOP pathway of the UPR is a highly conserved ER- 
stress-specific mechanism of regulation of NKG2D-ligands. Inte-
restingly, ER stress is a common pathophysiological phenomenon 
in the two disease processes that have been mostly linked to 
NKG2D-ligand expression, namely cancer, discussed below, and 
(viral) infection. Viral infection can strongly induce NKG2D-
ligands. For example, human immunodeficiency virus type 1 
(HIV-1) induces DNA stress/damage checkpoint arrest initiated 
by the DNA damage-sensing protein kinase (ataxia telangiectasia-
mutated and Rad3-related: ATR) (28), resulting in upregulation 
of NKG2D-ligands (29, 30). Recognition of viral products, such as 
double-stranded (dsRNA), by retinoic acid-inducible gene I and 
melanoma differentiation-associated gene 5, both cytoplasmic 
pattern recognition receptors, also upregulate MICA and ULBP2 
expression (31). Since viral replication requires the host ER for 
the production of their structural and non-structural proteins, 
viral infection has been strongly associated with activation of the 
UPR as well, and further research is required to investigate how 
the UPR in viral infection affects NKG2D-ligand expression.
Consequences of eR Stress-induced 
Regulation of nKG2D-Ligands in the 
Gastrointestinal Tract
In genome-wide association studies, MICs gene have been asso-
ciated with susceptibility to a variety of autoimmune diseases, 
including systemic type 1 diabetes, rheumatoid arthritis, and 
lupus erythematosus (32–34). Consequently, NKG2D/NKG2D 
ligand interactions have been hypothesized to be involved in their 
pathogenesis (35–38).
In the intestine, NKG2D/NKG2D-ligand interactions have 
mainly been studied in celiac disease. Celiac disease is a gluten-
driven innate and acquired immune cell-mediated enteropathy 
characterized by findings of intraepithelial lymphocytosis, crypt 
hyperplasia, and villous atrophy, and a positive response to a 
gluten free-diet (39). The fractions of NKG2D+ NK  cells and 
NKT cells among the intraepithelial mononuclear cells in active 
celiac disease are significantly increased as compared to inactive 
celiac disease or control subjects (40). Increased MICA expres-
sion on the intestinal epithelium in active celiac disease via a 
pathway involving IL-15 induction by gliadin triggers activation 
of intraepithelial T  cells, allowing for the killing of intestinal 
epithelial cells (41). Details of the MICA/B expression pattern 
showed that the expression was observed not only on epithelial 
cells but also in the cytoplasm of intraepithelial T lymphocytes 
in patients with active celiac disease, suggesting extensive stress 
conditions are present in active celiac disease (42). Interestingly, 
some studies have suggested that ER stress could be involved in 
NKG2D-ligand expression regulation in celiac disease (42).
In Crohn’s disease, several studies have also suggested involve-
ment of the NKG2D/NKG2D-ligand pathways in the patho-
genesis of this disorder (43–45). Specifically, MICA and MICB 
expression has been demonstrated to be increased on intestinal 
epithelial cells in patients with inflammatory bowel disease 
(46, 47). Moreover, a subset of CD4+ T cells expressing NKG2D was 
increased in patients with Crohn’s disease and functionally active 
FiGURe 1 | Endoplasmic reticulum (ER) stress-inducing murine UL16-binding protein like transcript 1 (MULT1) in mouse. MULT1 [encoded by UL16 binding protein 1 
(Ulbp1)], but not other natural-killer group 2 member D (NKG2D)-ligands, mRNA, and surface expression are upregulated on ER-stressed mouse small intestinal epithelial 
cells. This occurs through activating factor 4 (ATF4) and/or C/EBP homologous protein (CHOP) presumably downstream of the protein kinase RNA-like ER kinase 
pathway. CHOP as a transcription factor binds directly to the promoter area of Ulbp1, which upon expression subsequently activates NKG2D-expressing intraepithelial 
group 1 innate lymphoid cells (ILCs) [natural killer (NK) cells and ILC1] that accumulate within the intestinal epithelium and promote small intestinal inflammation.
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through MICA–NKG2D interactions, leading to interferon-γ 
pro duction. In pediatric Crohn’s disease and ulcerative colitis, 
ULBP1 and ULBP2 is upregulated on infiltrating immune cells 
in active inflammatory lesions (48). Interestingly, a recent clinical 
trial revealed efficacy of a blocking anti-NKG2D IgG4 antibody 
in patients with active Crohn’s disease (49), suggesting that 
NKG2D/NKG2D-ligand interactions are of importance in the 
pathogenesis of Crohn’s disease.
As ER stress has also been linked to the pathogenesis of 
Crohn’s disease (50), and as we demonstrated that ER stress 
regulates NKG2D-ligands on intestinal epithelial cells, we sub-
sequently investigated the functional consequences of epithelial 
ER stress-induced NKG2D-ligand expression and its role in the 
development of spontaneous enteritis in a mouse model of this 
condition. We demonstrated that increased MULT1 expression 
on intestinal epithelial cells of Xbp1ΔIEC mice was accompanied 
by increased quantities of NKG2D-expressing intraepithelial 
group 1 ILCs (NK cells and ILC1) (25). The group 1 ILCs within 
the epithelium also exhibited evidence of increased activation as 
demonstrated by increased surface expression of NKG2D and 
CD25. Indeed, IELs from Xbp1ΔIEC mice exhibited increased 
cytotoxicity in comparison to the activity observed with IELs 
from wild-type mice, suggesting an involvement in inflamma-
tion, which was supported by amelioration of inflammation upon 
NKG2D blockade. Furthermore, ER stress-induced intestinal 
inflammation due to Xbp1 deletion in the intestinal epithelium 
was uniquely comprised of a significant component of innate 
immune activation as concomitant loss of the adaptive immune 
system in Rag1−/−Xbp1ΔIEC double mutant mice did not affect the 
severity or kinetics of the inflammation. However, depletion of 
NK  cells significantly diminished inflammation that emerged 
from tamoxifen-driven, and thus temporally controlled induc-
tion of ER stress during adult life in Xbp1T-ΔIEC mice. Similarly, 
spontaneous enteritis was reversed by NKG2D blockade in 
Xbp1T-ΔIEC mice, in line with what has been shown for mouse 
colitis models (51, 52). Thus, our study demonstrates that ER 
stress in the small intestine leads to spontaneous enteritis that 
depends significantly on the presence of an innate immune 
system. Further, the development of ER-stress-mediated inflam-
mation in this context involves the CHOP-dependent induction 
of NKG2D-ligand MULT1 and its recognition by NKG2D on 
group 1 ILC, which are increased in the intestinal epithelium. 
Future studies are required to investigate how ER stress is linked 
to NKG2D-ligand expression in the human gut, particularly in 
the setting of complex diseases including inflammatory bowel 
disease. Methods to resolve pathologic levels of ER stress could, 
therefore, be a potential target for therapies in this still uncurable 
disease.
FiGURe 2 | CEA-related cell adhesion molecule 1 (CEACAM1) regulating natural-killer group 2 member D (NKG2D)-ligands expression and NKG2D function. 
CEACAM1 regulates glycosylation of NKG2D-ligands, resulting in downregulation of the NKG2D-ligand expression on the cell surface of the tumor cell. CEACAM1 
induced by interleukin-2 inhibits NKG2D-mediated cytotoxic function through recruitment of Src homology phosphatase 1 (SHP1) to phosphorylated CEACAM1 
which leads to dephosphorylation of Vav1 on the natural killer (NK) cell. CEACAM1 on the NK cell and tumor cell interact homophilically through the N-domain of 
CEACAM1.
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Regulation of nKG2D-Ligand expression 
in Cancer
NKG2D-ligand expression has been exten sively studied in the 
setting of cancer. The expression of NKG2D-ligands in cancer 
can be hypothesized to serve in activating the immune system 
for elimination of the excessively proliferating cancer cells. E2F 
transcription factors, for example, regulate cell proliferation but 
at the same time can induce specific NKG2D-ligands such as 
RAE-1, but not MULT1 and H60 in mouse fibroblasts by directly 
binding the promoter region of Raet1 genes (53).
DNA damage responses to genotoxic stress coordinates acti-
vation of transcription, cell cycle control, apoptosis, and DNA 
repair processes mediated by a number of protein kinases, includ-
ing ATM (ataxia telangiectasia mutated) and ATR (ATM and 
Rad3-related) protein kinases (54). In both mouse and human 
non-tumor cells, genotoxic stress and inhibition of DNA replica-
tion via the DNA damage pathway through ATM or ATR protein 
kinases, leads to increased surface expression of NKG2D-ligands 
(55). In tumor cell lines, constitutive ligand expression on the cell 
surface is suppressed by pharmacological or genetic inhibition of 
ATR, ATM, or Chk1 (55).
p53, induced in response to DNA damage, can also regulate 
human ULBP1 and ULBP2 by binding to p53-responsive 
elements in the promoter area of ULBP1 and ULBP2 gene 
(56–58). However, several microRNAs that are induced by 
p53 (miR-34a and miR-34c) have been shown to suppress 
ULBP2 expression by directly binding to the 3′-UTR of ULBP1  
mRNA (59).
Other mechanisms of NKG2D-ligand induction in response 
to DNA damage response include the stimulator of interferon 
genes (STING)-dependent DNA sensor pathway (60). The accu-
mulation of cytosolic DNA by DNA damage response activates 
STING-dependent DNA sensors, leading to the activation of 
TANK binding kinase 1 and interferon regulatory factor 3, which 
in turn are associated with RAE1 expression (60).
inhibition of nKG2D-Ligand expression on 
Tumor Cells by CeACAM1
As NKG2D-ligand expression on tumor cells is critical for the 
recognition and clearance of tumors, tumor cells have evolved by 
developing several mechanisms to escape from immune surveil-
lance. Several studies have demonstrated that soluble forms of 
NKG2D-ligands that were derived from cancer cells by either 
proteolytic shedding (61–63), alternative splicing (64), or exo-
some secretion (65) can impair NKG2D-mediated cytotoxicity by 
negatively regulating NKG2D expression or recognition (66). In 
addition, metastasis-associated microRNA miR-10b (also known 
as metastamir), which promotes tumor invasion and metastasis 
by targeting multiple genes, downregulates MICB expression by 
binding directly to the 3′-UTR of MICB (67).
CEACAM1, a member of the CEA family of Ig like transmem-
brane glycoproteins (68), is involved in the negative regulation 
of NKG2D-ligands in cancer (69–71). CEACAM1 is expressed 
in mouse and humans and is characterized by numerous 
transmembrane isoforms that derived from alternative splic-
ing mechanisms [reviewed in Ref. (68, 72)]. This mechanism 
generates CEACAM1 variants that share a membrane distal 
IgV-like domain (N-domain), which functions in homophilic or 
heterophilic interactions, that is coupled to variable numbers of 
IgC2 domains and linked to either a long (L) or short cytoplasmic 
domain. NK cells and T cells predominantly express CEACAM1-L 
isoforms that contain two immunoreceptor tyrosine-based inhibi-
tory motifs in their cytoplasmic tail which serves to recruit Src 
homology phosphatase 1 (SHP1) and SHP2 after phosphorylation 
by Src-related kinases (68, 73). Ligation of CEACAM1-L isoforms 
on NK cells by CEACAM1 on tumor cells suppresses NK cytol-
ytic function as CEACAM1 on the NK cells negatively regulates 
NKG2D signaling (74). Specifically, recruitment of SHP1 by 
CEACAM1 leads to dephosphorylation of the guanine nucleo-
tide exchange factor Vav1, one of the most proximal elements 
associated with NKG2D-mediated cytolytic signaling (75). At the 
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same time, CEACAM1 expression on the tumor cells has been 
shown to regulate NKG2D-ligand expression. Specifically, silenc-
ing of CEACAM1 in mouse and human tumor cells upregulates 
expression of NKG2D-ligands on the cell surface of the tumor 
cell and makes them more highly susceptible to NK cell-mediated 
cytotoxicity (Figure 2) (76). Silencing CEACAM1 did not alter 
the transcriptional levels of NKG2D-ligands. Indeed, cell surface 
expression of RAE-1 was increased in CEACAM-1 silenced cells, 
whereas intracellular RAE-1 protein was decreased in comparison 
to non-silenced cells. Furthermore, RAE-1 on the cell surface of 
CEACAM1 silenced cells possessed an increased quantity of car-
bohydrate side-chain modifications in comparison to CEACAM1 
non-silenced cells, in which RAE-1 accumulates intracellularly 
as an incompletely glycosylated protein (76). Thus, CEACAM1 
can regulate glycosylation of NKG2D-ligands resulting in the 
NKG2D-ligands retention in an intracellular compartment.
COnCLUSiOn
NKG2D/NKG2D-ligands interactions play a critical role in 
the immune surveillance of sick cells, such as those that are 
infected or have undergone neoplastic transformation. In 
such contexts, the expression and function of NKG2D and 
NKG2D-ligands are critical for removal of the altered cells 
and resolution of the condition. However, in certain circum-
stances cancer and infected cells have developed the ability 
to avoid immune surveillance that is mediated by NKG2D/
NKG2D-ligands which allows progression of the infection 
or tumor. Our recent studies indicate that CEACAM1 plays 
an important role in NKG2D/NKG2D-ligand function and 
expression, respectively, suggesting that manipulation of this 
pathway may be beneficial in such disorders. On the other 
hand, NKG2D/NKG2D-ligand expression and function may 
inappropriately be associated with distressed organs or cells in 
autoimmune disease, suggesting that their blockade would be 
an important means of resolving inflammation consistent with 
their current evaluation in clinical trials in inflammatory bowel 
disease (49). Our recent studies thus suggest that enhancement 
of CEACAM1 function might be beneficial in such disorders 
by enhancing inhibition of NK and ILC1-mediated activation 
due to NKG2D/NKG2D ligand interactions. This is consistent 
with previous studies that application of CEACAM1 ligands to 
mouse models of colitis can suppress inflammation (77). This is 
particularly interesting as a key feature of inflammatory bowel 
disease which is the common induction of ER stress within the 
intestinal epithelium, which can serve as nidus for development 
of inflammation (22, 50). As such, the recent evidence that ER 
stress is linked to the upregulation of specific NKG2D-ligand 
and activation of intraepithelial NK  cells and ILC1, together 
imply that blockade of NKG2D and NKG2D ligand interac-
tions may have wide benefit in inflammatory bowel disease and 
potentially other autoimmune conditions.
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